Interventions in antipsychotics-treated patients with cardiometabolic risk factors or metabolic syndrome

被引：1
|
作者：
Larsen, J. [1 ]
Holdrup, M. [2 ]
Christensen, B. [3 ]
Sigalin, C. [4 ]
Nilsson, P. M. [5 ]
Kolb, S. [6 ]
机构：
[1] Odense Univ Hosp, Dept Psychiat, Odense C, Denmark
[2] 3MDS Pharma Serv, Copenhagen, Denmark
[3] Aalborg Psychiat Hosp, Dept Psychiat, Aalborg, Denmark
[4] Ryhov Cty Hosp, Dept Psychiat, Jonkoping, Sweden
[5] Malmo Univ Hosp, Dept Clin Sci, Malmo, Sweden
[6] Pfizer, Med Affairs, Walton Oaks, England
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2008年 / 18卷
关键词：
D O I：
10.1016/S0924-977X(08)70648-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S440 / S441
页数：2
相关论文
共 50 条
  • [41] Risk Factors for Metabolic Effects of Atypical Antipsychotics
    Thurston, Maria M.
    Duncan, Erica
    BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 212S - 212S
  • [42] Metabolic Syndrome and Oral Markers of Cardiometabolic Risk
    Tremblay, Monique
    Gaudet, Daniel
    Brisson, Diane
    JOURNAL OF THE CANADIAN DENTAL ASSOCIATION, 2011, 77 : 1 - 7
  • [43] Sensitive Biomarkers of Metabolic Risk in Children Treated with Antipsychotics
    Nicol, Ginger E.
    Yingling, Michael D.
    Schweiger, Julia A.
    Newcomer, John W.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S111 - S112
  • [44] The Association of Serum Circulating Neuropeptide Q and Chemerin Levels with Cardiometabolic Risk Factors among Patients with Metabolic Syndrome
    Pelczynska, Marta
    Mikulska, Aniceta Ada
    Czyzewska, Krystyna
    Bogdanski, Pawel
    Grzelak, Teresa
    BIOMOLECULES, 2021, 11 (12)
  • [45] δ-Tocotrienol in Combination with Resveratrol Improves the Cardiometabolic Risk Factors and Biomarkers in Patients with Metabolic Syndrome: A Randomized Controlled Trial
    Fatima, Safia
    Khan, Dilshad Ahmad
    Aamir, Muhammad
    Pervez, Muhammad Amjad
    Fatima, Fozia
    METABOLIC SYNDROME AND RELATED DISORDERS, 2023, 21 (01) : 25 - 34
  • [46] Prevalence of metabolic syndrome among schizophrenia patients treated with monotherapy atypical antipsychotics in Malaysia
    Sulaiman, A. H.
    Said, M. A.
    Habil, M. H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 136 - 136
  • [47] Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia
    Said, Mas Ayu
    Sulaiman, Ahmad Hatim
    Habil, Mohd Hussain
    Das, Srijit
    Abu Bakar, Abdul Kadir
    Yusoff, Rosliwati Md
    Loo, Tsui Huei
    Abu Bakar, Shamshunnisah
    SINGAPORE MEDICAL JOURNAL, 2012, 53 (12) : 801 - 807
  • [48] Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
    Boiko, Anastasiia S.
    Mednova, Irina A.
    Kornetova, Elena G.
    Gerasimova, Valeria I.
    Kornetov, Alexander N.
    Loonen, Anton J. M.
    Bokhan, Nikolay A.
    Ivanova, Svetlana A.
    PHARMACEUTICALS, 2021, 14 (05)
  • [49] LIFESTYLE INTERVENTIONS ON WEIGHT LOSS AND CARDIOMETABOLIC RISK FACTORS
    Goodpaster, B.
    ANNALS OF NUTRITION AND METABOLISM, 2013, 63 : 28 - 28
  • [50] Differential Impact of Maternal and Paternal Metabolic Syndrome on Offspring's Cardiometabolic Risk Factors
    Park, Jun-Hong
    Shim, Young Suk
    Lim, JungSub
    Hwang, Jin Soon
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 146 - 146
12345